KEYTRUDA® + LENVIMA® Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma

After four years of follow-up, KEYTRUDA plus LENVIMA reduced the risk of death by 21% versus sunitinib in the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581...

May 26, 2023 | Friday | News
Overcoming Solid Tumor Treatment Hurdles With mRNA-based CAR T-cells

In contrast to the success of CAR T-cell therapies in liquid cancers, development for the treatment of solid tumors, including glioblastoma, has progressed...

May 23, 2023 | Tuesday | News
Researchers Reveal Newfound DNA Repair Mechanism

Published online May 16 in the journal Cell, the report describes the molecular mechanism behind a DNA repair pathway that counters the mistaken inclusion ...

May 18, 2023 | Thursday | News
Why Use Fluorescent Probes in Your In Vivo Imaging Studies

Key Advantages of Using In Vivo Fluorescence Imaging Non-invasive approach In vivo fluorescence imaging is a non-invasive technique that uses light to vi...

May 16, 2023 | Tuesday | News
New Developments Show Ophthalmology Embracing Myopia Control & Management

Two newly published pieces indicate that the ophthalmology community is more broadly embracing myopia control and management, according to global cat...

May 09, 2023 | Tuesday | News
Unleashing The Potential of Immunology To Improve Public Health

Largely driven by increasing incidence of chronic and infectious diseases and growth in biotechnology and pharma industries, the global immunoassay market ...

May 05, 2023 | Friday | News
Could Tumoroids Solve the Problem of High Attrition in Cancer Trials?

There is growing recognition that the experimental model systems used in many cancer research projects, which include 2D cell cultures, patient-derived xen...

May 01, 2023 | Monday | News
Study Suggests Catalyst for Human Brain Evolution

More than a million years ago, large chunks of the human genome were rearranged—a chance event during egg or sperm formation that led to the deletion...

May 01, 2023 | Monday | News
Pfizer and Astellas' XTANDI® Combo Proves Effective in Reducing Prostate Cancer Metastasis Risk by 58%: Phase 3 EMBARK Trial Results Revealed

Data from Phase 3 EMBARK trial to be presented as a plenary session during the 2023 American Urological Association Annual Meeting Res...

May 01, 2023 | Monday | News
How CRISPR Is Changing Cancer Research and Treatment

But a game-changer occurred in 2013, when several researchers showed that a gene-editing tool called CRISPR could alter the DNA of human cells like a v...

April 27, 2023 | Thursday | News
Trust Your Gut: Balancing the Microbiome for Better Health

A balanced microbiome plays an important role in maintaining human health by promoting protective immune responses and limiting excessive inflammation. But...

April 25, 2023 | Tuesday | News
Overcoming Challenges in CHO Host Cell Protein Detection and Quantification

Regulatory authorities such as the FDA therefore require manufacturers to monitor and demonstrate HCP clearance, and to report the amount of HCP impurities...

April 21, 2023 | Friday | News
Scientists Discover Key Role of Glucose in Brain Activity

The human brain has a sweet tooth, burning through nearly one quarter of the body's sugar energy, or glucose, each day. Now, researchers at Gladstone Insti...

April 19, 2023 | Wednesday | News
Overcoming Throughput, Standardization, And Analysis Challenges for Human Midbrain Organoids

Organoids also hold advantages over animal models, which inherently possess species-dependent differences and can be logistically and ethically challenging...

April 17, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close